不同样本储运方式应用于HIV基因型耐药检测的研究进展
摘要
高效抗逆转录病毒疗法（highlyactiveantiretroviraltherapy，HAART）大大降低了HIV／AIDS患者的发病率与死亡率。尽管如此，HAART的广泛应用经常伴随HIV耐药性的发生。HIV耐药（HIVdrugresistance）可以导致抗病毒治疗失败风险增加、耐药病毒株传播、抗病毒药物选择减少及HIV／AIDS患者存活率降低等。
出处
《中华实验和临床病毒学杂志》
CAS
CSCD
2015年第4期381-382,共2页
Chinese Journal of Experimental and Clinical Virology
基金
国家高技术研究发展计划资助项目（2011AA02A115）
参考文献24
-
1Pa|elia FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med, 1998, 338:853-860.
-
2Parkin N, de Mendoza C, Schuurman R, et al. Evaluation of In- house Genotyping Assay Performance Using Dried Blood Spot Specimens in the Global World Health Organization Laboratory Network. Clin Infect Dis, 2012, Suppl 4 :$273-279.
-
3Eshleman SH, Hackett J Jr, Swanson P, et al. Performance of the Celera Diagnostics ViroSeq H1V-1 Genotyping System for sequence-based analysis of diverse human immunodeficiency virus type 1 strains. J Clin Mierobiol, 2004, 42:2711-2717.
-
4WHO (2010) WHO/HIVResNet HIV Drug Resistance Laboratory Strategy. http://www, who. int/hiv/puh/drugresistance/hiv reslab_strategy, pdf. Accessed 2010 Sep 3.
-
5Aghokeng AF, Mpoudi-Ngole E, Chia JE, et al. High failure rate of the ViruSeq HIV-1 genotyping system for drug resistance testing in Cameroon, a country with broad HIV-1 genetic diversity. J Clin Microbiol, 2011, 49 : 1635-1641.
-
6Beddows S, Galpin S, Kazmi SH, et al. Performance of two commercially available sequence-based HIV-1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypes. J Med Virol, 2003, 70:337-342.
-
7Chew CB, Potter SJ, Wang B, et al. Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART. J Clin Virol, 2005, 33:206-216.
-
8Smith DM, Wong JK, Shao H, et al. Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission. J Infect Dis, 2007, 196 : 356-360.
-
9Poveda E, Briz V, Paraskevis D, et al. Dynamics of drug- resistant HIV-1 in plasma and peripheral blood ceils in patients during and after enfuvirtide therapy. AIDS Res Hum Retroviruses, 2007, 23:1078-1082.
-
10Bon I, Gibellini D, Borderi M, et al. Genotypic resistance in plasma and peripheral blood lymphocytes in a group of naive HIV- 1 patients. J Clin Virul, 2007, 38:313-320.
-
1卢祥婵,伍秋云,黄爱春,何华伟,朱庆东,谢志满,李清蓉,阮光靖,苏绮思,吴锋耀.AIDS合并结核病患者抗结核联合HAART治疗后HIV基因型耐药研究[J].广西医学,2015,37(2):157-159. 被引量：4
-
2王凤英,董永慧,阿迪力,玛尔哈巴.2005年新疆HIV耐药性专项调查[J].中国艾滋病性病,2007,13(2):165-165.
-
3王凤香,乔晓春,曲淑霞.山西省HIV耐药监测结果分析[J].中华现代皮肤科学杂志,2005,2(5):468-468.
-
4王海燕.HIV基因型和药代动力学可预测基于那非那韦HAART疗法的有效性[J].传染病网络动态,2002(9):9-9.
-
5温韬.模拟表型有助于鉴定HIV耐药性[J].传染病网络动态,2003(6):24-24.
-
6张杰敏.山西省HIV/AIDS抗病毒治疗耐药性监测结果分析[J].山西中医学院学报,2007,8(1):49-50. 被引量：1
-
7邹潇白,贺健梅,张国强,李向忠,彭瑾瑜,陈曦.湖南省艾滋病患者抗病毒治疗后耐药性分析[J].中国感染控制杂志,2010,9(5):305-309. 被引量：11
-
8陈亮,吴南屏.艾滋病病毒耐药性研究的概况及进展[J].国外医学（流行病学．传染病学分册）,2005,32(3):159-161. 被引量：10
-
9谭俊,王丽丽.动脉粥样硬化中脂质储运、外流模式及其调节[J].心血管病学进展,2006,27(z1):98-102.
-
10高丽,杨绍敏.HIV／AIDS患者高效抗病毒治疗及耐药性研究[J].世界感染杂志,2009,9(1):57-60.
